Panacea Life Sciences(OTC) PLSH

Panacea Life Sciences Holdings, Inc. operates as an integrated research and production firm, specializing in cannabinoid and nutraceutical products. The company focuses on developing natural, pharmaceutical-grade alternatives for both human and pet consumption.

Products and Services

• Offers a diverse range of cannabinoid products including softgels, gummies, and tinctures
• Involved in personal protective equipment (PPE) market, distributing hand sanitizers and masks
• Provides white-label and contract manufacturing services to other cannabinoid companies

Growth Outlook

• Recent quarterly revenue increased to $118,812, showing potential for growth
• Strong market demand for cannabinoid products supports future expansion
• Established in 2008, the company has a solid foundation for long-term growth

Financial Highlights

• Trailing twelve months (TTM) revenue of $1,000,000 indicates a growing business
• Current ratio of 6.03 suggests strong liquidity and financial health
• Net income for the latest quarter was -$3,560,271, highlighting ongoing challenges

Panacea Life Sciences Holdings, Inc. is positioned in the healthcare sector, focusing on innovative cannabinoid and nutraceutical solutions. The company has a diverse product portfolio and is actively involved in the PPE market, which adds to its revenue streams. Recent financial data indicates a revenue increase, although challenges remain evident in net income figures. The company's strong liquidity position, as indicated by a current ratio of 6.03, suggests it can navigate through its current financial hurdles. With a solid foundation and growing market demand, Panacea Life Sciences presents an intriguing opportunity for potential investors interested in the cannabinoid industry.